Galectin-10 forms Charcot–Leyden crystals, which are observed in various eosinophilic diseases and can act as a biomarker for disease activity, diagnosis, and treatment effectiveness in eosinophilic diseases like asthma, eosinophilic esophagitis, rhinitis, and atopic dermatitis. Here, CLC is linked to eosinophil disorder.